BIO has officially announced that Ambassador Darci Vetter, Chief Agricultural Negotiator of the Office of the U.S. Trade Representative, will deliver the keynote address during the Food and Agriculture track at the 2016 BIO International Convention.  BIO 2016 will be held June 6-9, 2016 in San Francisco, California at the Moscone Center.

Today, the Biotechnology Innovation Organization (BIO) applauds Reps. Sean Duffy (R-WI) and John Carney (D-DE) for introducing the Corporate Governance Reform and Transparency Act. 

Today, the Biotechnology Innovation Organization (BIO) released the largest study ever of clinical development success rates. The study, conducted in partnership with Amplion and Biomedtracker, recorded and analyzed 9,985 clinical and regulatory phase transitions, across 1,103 companies. Using clinical trial data from the past decade, “Clinical Development Success Rates 2006-2015” compares groups of diseases, drug modalities and other attributes to generate the most comprehensive analysis, to date, of biopharmaceutical R&D success.

BIO applauds the US House of Representatives for passing H.R. 4139, the Fostering Innovation Act.  The bipartisan legislation was introduced by Reps. Kyrsten Sinema (D-AZ) and Michael Fitzpatrick (R-PA).

The Biotechnology Innovation Organization (BIO) and Arizona BioIndustry Association (AZBio) commend Governor Doug Ducey for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines.

Senate Ag Committee Efforts Will Better Address Transparency Washington, D.C. (May 19, 2016) – During markup of the FY17 Agriculture Appropriations Bill, the Senate Appropriations Committee approved today by voice vote an amendment to mandate the identification of genetically engineered salmon as “genetically engineered” or “GE” in the marketplace. 

Today, the Biotechnology Innovation Organization (BIO) released a new report - Emerging Therapeutic Company Investment and Deal Trends – highlighting ten years (2006-2015) of biotechnology funding and deal making across five areas: venture capital, IPOs, follow-on public offerings, licensing, and acquisitions. 

The Honorable Newt Gingrich, Candy Crowley and Stephanie Cutter to participate on keynote panel Wednesday, June 8.A former Speaker of the House, an award winning journalist and a top political strategist will lead a spirited discussion on the 2016 presidential election and its potential impact on the biotechnology industry and the global economy at the 2016 Biotechnology Innovation Organization (BIO) Convention.

The proposed rule for the 2017 Renewable Fuel Standard (RFS), issued today by the Environmental Protection Agency (EPA), fails to put the program fully back on track and continues to create uncertainty for advanced and cellulosic biofuel producers and their investors.